Abstract. Psychostimulants including amphetamines and cocaine, opioids including morphine, and some recreational drugs share the ability to cause drug dependence and addiction. Although these drugs of abuse primarily act on distinct molecular targets, such as monoamine transporters or receptors, they finally converge to common neural pathways. Several lines of evidence suggest that their chronic treatment leads to the enhancement of the mesocorticolimbic dopaminergic neurons from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) and the medial prefrontal cortex (mPFC) and leads to abnormal glutamatergic function from the mPFC to the NAc and VTA. The neural adaptation of dopaminergic-glutamatergic system is considered to be critically implicated in neuropsychotoxic effects of these drugs of abuse. In addition, recent studies suggest that the serotonergic neurons from the raphe nuclei to limbic areas modulate the mesocorticolimbic dopaminergic-glutamatergic system and participate in the neuropsychotoxicity. In this review, our recent in vitro studies on the molecular targets and neural adaptation of methamphetamine, 3,4-methylenedioxymethanphetamine (MDMA, "ecstasy"), and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT, "foxy") using Xenopus oocytes, organotypic slice cultures of the mesocorticolimbic dopaminergic-glutamatergic system, and the raphe serotonergic system are introduced.
Introduction
Psychostimulants including amphetamines and cocaine, opioids including morphine, and some recreational drugs share the ability to cause drug dependence and addiction. Although these drugs of abuse primarily act on distinct molecular targets, such as monoamine transporters or receptors, it is considered that they finally converge to a common neural pathway and neurotransmitters that produce their rewarding effects. Several lines of evidence suggest that their repeated treatment leads to the progressive enhancement of the mesocorticolimbic dopaminergic neurons from the ventral tegmental area (VTA) to the nucleus accumbens (NAc), the medial prefrontal cortex (mPFC), and other forebrain regions. The psychological effects of amphetamine and methamphetamine (METH) are mainly attributed to their binding to, and reversal of the dopamine transporter (DAT) function, resulting in both reuptake inhibition and release of dopamine at the mesocorticolimbic dopaminergic nerve terminals, while cocaine inhibits reuptake of monoamines. Opioids inhibit the inhibitory GABAergic interneurons in the VTA through µ-opioid receptor activation and subsequently activate the mesocorticolimbic dopaminergic neurons (1) . On the other hand, some recreational drugs produce their psychological effects through interaction with the serotonergic system. 3,4-Methylenedioxymethanphetamine (MDMA, "ecstasy"), which is an amphetamine derivative, mainly releases serotonin (5-HT) from serotonergic neurons after uptake by serotonin transporter (SERT) as a substrate, while it interacts to a lesser extent with the dopaminergic system indirectly via the serotonergic activation and directly via DAT (2, 3). 5-Methoxy-N,N-diisopropyltryptamine (5-MeODiPT, "foxy"), which is a designer hallucinogen derived from tryptamine, is recently reported to act on the 5-HT 2A receptor (4) and SERT (5, 6) , although the mechanisms of its action still remain unclear. Recent studies suggest that the serotonergic neurons from the raphe nuclei to limbic areas modulate the mesocorticolimbic dopaminergic-glutamatergic system (7) and participate in the neuropsychotoxicity induced by drugs of abuse (8 -10) . Here, we introduce our recent in vitro studies: 1) electrophysiological analysis of action of MDMA and 5-MeO-DiPT on SERT using the Xenopus oocyte expression system; 2) effect of METH and other drugs of abuse on the dopaminergic system using mesocorticolimbic organotypic slice co-culture; and 3) effect of METH, MDMA, and 5-MeO-DiPT on the serotonergic system using a mesencephalic organotypic slice culture including the raphe nuclei.
Electrophysiological analysis for the effect of MDMA and 5-MeO-DiPT on SERT using the Xenopus oocyte expression system SERT belongs to a Na + -dependent transporter of solute carrier family, responsible for reuptake of 5-HT following their release to the synaptic cleft. It is believed that transport of a positively charged 5-HT molecule by SERT is coupled to influx of one or more Na + , one Cl − , and countertransport of one K + or H + (11) . A body of evidence suggests that the substrate 5-HT, Na + , and Cl − bind to outward-facing sites in the transmembrane domains of SERT and that the binding events trigger a conformational change of SERT to transport them from outside to inside (12, 13) . This classical model predicts that no net charge crosses the membrane during a transport cycle, which is supported by many findings that 5-HT uptake via SERT was not affected by membrane potential (11) . However, electrophysiological studies using the Xenopus oocyte expression system revealed multiple conducting states of rat SERT. One of them is a substrate-and Na + -dependent inward current that is associated with substrate transport. The transportassociated current is carried mostly by Na + . In this study, we have examined the actions of MDMA, 5-MeO-DiPT, and other substrates on the transport-associated current in rat SERT expressed in Xenopus oocytes.
In SERT-expressed oocytes, application of 5-HT, dopamine, and MDMA dose-dependently evoked a steady-state, transport-associated inward current, while only the highest concentration of norepinephrine evoked a small inward current. The rank order of potency is 5-HT>MDMA>dopamine>>norepinephrine. The I max value of MDMA was almost equal to that of 5-HT and dopamine. The current responses were inhibited by a 5-HT specific reuptake inhibitor (SSRI), citalopram, or by substitution of extracellular Na + with N-methyl-Dglucamine (14) . On the other hand, in DAT-expressed oocytes, application of MDMA and substrates dosedependently evoked a transport-associated inward current response, while the I max value of MDMA was lower than other amine substrates with the following rank order of potency: dopamine>norepinephrine>5-HT>MDMA. These results suggest that MDMA could be transported mainly thorough SERT and weakly, but at least in part, through DAT as a substrate, consistent with previous binding reports (15) . In addition, since rapid increase in the CNS lactate level is suggested in the use of MDMA (16), we investigated the effects of physiologically-relevant increase in hydrogen ion concentration (pH 6.4) on the transport-associated inward current of SERT. At pH 6.4, the K m values of 5-HT and dopamine for the transport-associated current were not altered, while that of MDMA was 3-times lower under the acidic condition, compared to neutral condition (pH 7.4). These results suggest that the effect of MDMA is potentiated under acidic conditions (14) .
On the other hand, application of 5-MeO-DiPT to SERT-expressed oocytes induced an apparent outward current response. Similar outward current was also observed in the case of cocaine and citalopram. It is considered that the apparent outwardly directed current response is due to blockade of SERT-associated leakage current that is substrate-independent. Consequently, these data suggest that 5-MeO-DiPT is not transported via SERT as a substrate, but may act as a blocker-type inhibitor for SERT, like cocaine and SSRIs (Fig. 1 ). This is consistent with the previous finding that 5-MeO-DiPT could inhibit [
3 H]5-HT uptake and 5-HT releasing action of METH (6) . On the hand, application of 5-MeO-DiPT evoked no detectable current in DAT-expressed oocytes.
Acute and chronic effect of METH and other drugs of abuse on dopaminergic neurons using mesocorticolimbic organotypic slice co-culture
In rodents, repeated intermittent exposure to METH and other many drugs of abuse leads to progressive augmentation of their locomotor activating effects. This phenomenon, termed behavioral sensitization, is thought to underlie certain aspects of drug addiction. Several lines of evidence suggest the critical involvement of the mesocorticolimbic dopaminergic neurons, which project from the VTA to the NAc and mPFC (17) . It has been reported that the METH-induced increase in dopamine release is augmented in the NAc and mPFC following repeated treatment with METH (18, 19) . On the other hand, the mesocorticolimbic dopaminergic neurons could be regulated by the glutamatergic neurons, which project from limbic and cortical areas, such as the mPFC, hippocampus, and amygdala to the VTA and NAc. A body of evidence suggests that neuroadaptations in interaction between the mesocorticolimbic dopaminergic and glutamatergic system by repeated drugs of abuse treatment play an important role in drug addiction (20) , although the mechanisms are still unclear.
To elucidate the mechanisms of the neuroadaptation underlying METH addiction, we have tried to reconstruct the mesocorticolimbic dopaminergic-glutamatergic system using rat organotypic slice co-cultures of the mesencephalic slice including the VTA, ventral striatal slice including the NAc, and mPFC slice. Organotypic slice co-cultures were prepared according to the methods described previously (21, 22) with slight modifications. Briefly, postnatal day 3 -4 rats were anesthetized by hypothermia, and the brain was removed from the skull and separated into two hemispheres. Coronal slices (350-µm-thick) were prepared under sterile conditions with a tissue chopper at the mesencephalic and telencephalic levels according to the Atlas of the Developing Rat Brain, as shown in Fig. 2 . Tissue samples were dissected for the mesencephalic slice including the VTA, ventral striatal slice including the NAc, and mPFC slice including the cingulate gyrus and infralimbic cortex. Slices were transferred onto Millicell-CM insert membranes (Millipore, Bedford, MA, USA) in six-well plates. A slice of each of VTA, NAc, and mPFC was arranged so that they contacted each other, as shown in Fig. 2 . Culture medium, consisting of 50% minimal essential medium / HEPES, 25% Hank's balanced salt solution, and 25% heat-inactivated horse serum supplemented with 6.5 mg / ml glucose and 2 mM l-glutamine, was supplied at a volume of 0.7 ml per each well. Slices were maintained for 18 -20 days before drug treatment in a 5% CO 2 humidified atmosphere at 37°C. Extracellular dopamine level was measured using a high-performance liquid chromatography (HPLC) system. The culture medium was aspirated and substituted with Krebs ringer buffer (KRB). Slices were pre-incubated with 0.7 ml of KRB for 15 min and then immediately replaced with an equivalent volume of fresh KRB containing drugs. After 30-min incubation, the buffer was collected. To quantify dopamine levels, the collected aliquot was automatically injected and analyzed by HPLC coupled with an electrochemical detector.
In the VTA / NAc / mPFC triple slice co-culture, immunohistochemical study revealed that tyrosine hydroxylase-positive, probably dopaminergic, cell bodies were abundantly observed in the VTA and their neurites projected to the NAc and mPFC, target regions observed in vivo (17, 23) , suggesting that the triple slice co-culture retained the in vivo morphology and projection of the mesocorticolimbic dopaminergic neurons. On the other hand, the mPFC has been shown to link to the NAc and VTA through the glutamatergic pathway (17, 20, 24, 25) . Maeda et al. (21) reported that in the same triple slice co-cultures, neurites of the mPFC extended, at least, into the NAc region, and the corticostriatal pathway had functional glutamatergic neurons using electrophysiological techniques. Taken together, it is considered that the mesocorticolimbic dopaminergic-glutamatergic system could be reconstructed in the VTA / NAc/ mPFC triple slice co-culture in vitro.
Single acute exposure of the VTA/ NAc/ mPFC triple slice co-culture to METH caused dopamine release in a concentration-dependent manner. Similarly, acute treatment with cocaine and morphine dose-dependently increased dopamine release. These results suggest that the triple slice co-culture has functional dopaminergic nerve terminals and inhibitory GABAergic interneurons in the VTA. On the other hand, although MDMA increased dopamine release, the effect was weaker than those of METH, cocaine, and morphine. This finding suggests that the direct action of MDMA on the dopaminergic neurons, probably via a DAT-mediated mechanism, is weak, as described above. However, in vivo dopamine release is known to be, at least in part, mediated through indirect mechanisms via MDMAinduced serotonergic activation (3), although the dopaminergic-serotonergic interaction in the VTA / NAc / mPFC triple slice co-culture has not been examined.
A number of in vivo studies have indicated that repeated intermittent treatment with METH and other drugs of abuse leads to the augmentation of mesocorticolimbic dopaminergic reactivity, which is thought to be the major cause of behavioral sensitization (18, 19, 26) . To examine the chronic effect of METH on dopamine release, the VTA / NAc/ mPFC triple slice co-culture was repeatedly exposed to METH at a relative lower concentration every 6 days. We found that the METHinduced dopamine release was gradually augmented by every repeated METH exposure. In addition, after the repeated exposure, challenge with METH to the repeated METH-exposed slices enhanced dopamine release, compared with that in the repeated PBS-exposed slices. Similar augmentation of dopamine release was observed by repeated exposure to cocaine and morphine. Therefore, we consider that drugs of abuse-induced augmentation of dopamine release, that is, dopaminergic sensitization, could be reproduced in vitro. Furthermore, we found that the glutamatergic system from the mPFC to the NAc and VTA plays an essential role in the repeated METH-induced mesocorticolimbic dopaminergic sensitization by using an NMDA-receptor antagonist and the VTA / NAc double slice co-cultures without the mPFC slice. Corresponding to our data, it was reported that NMDA-receptor antagonists and excitotoxic lesion of the mPFC prevented the development of METH-induced behavioral sensitization (27, 28) . Although in vivo studies have shown that glutamatergic afferents to the NAc from the amygdala and hippocampus, as well as the mPFC, are also involved in the behavioral sensitization (19, 20, 25) , the present findings directly indicated that the presence of the mPFC is essential and sufficient for induction of the mesocorticolimbic dopaminergic sensitization.
Acute and chronic effect of METH, MDMA, and 5-MeO-DiPT on serotonergic neurons using mesencephalic organotypic slice culture including the raphe nuclei Unlike amphetamines or cocaine, MDMA primary acts on SERT as a substrate, rather than DAT and norepinephrine transporter (2) . MDMA causes acute efflux of 5-HT from serotonergic neurons through SERT and leads to a long-term depletion of 5-HT that correlates with destruction of serotonergic nerve Fig. 2 . Preparation of rat organotypic VTA /NAc/mPFC triple slice co-cultures. A) Illustration of mesocorticolimbic dopaminergic and glutamatergic system. B) The mesencephalic slice including the VTA, ventral striatal slice including the NAc, and mPFC slice were prepared from postnatal day 3 -4 rats at a thickness of 350 µm and placed at the air-medium interface on Millicell-CM semiporous membranes. Each of three slices is arranged so that they contacted each other. Slices were maintained in a humidified atmosphere of 5% CO2 and 95% air at 37°C.
terminals (29, 30) . On the other hand, 5-MeO-DiPT is recently reported to act on 5-HT 2A receptors (4) and inhibit SERT (5, 6) as a blocker-type inhibitor, as described above. In the present study, we examined the acute and chronic effect of METH, MDMA, and 5-MeO-DiPT on serotonergic neurons using mesencephalic organotypic slice culture including the raphe nuclei.
The mesencephalic organotypic slice culture including the raphe nuclei were similarly prepared and cultured as described above. The coronal slices (350-µm-thick) were prepared at the mesencephalic levels including the dorsal raphe nuclei and the median raphe nuclei according to the Atlas of the Developing Rat Brain. Slices were maintained for 14 -16 days before starting drug treatment. For measurement of extracellular 5-HT release, the slices were pre-incubated with 0.7 ml of KRB for 15 min and then immediately replaced with an equivalent volume of fresh KRB containing drugs. After 30-min incubation, the buffer was collected. For measurement of intracellular 5-HT tissue content, the slices were homogenized and centrifuged, and the supernatants were collected. 5-HT level in the buffer or supernatant was analyzed by HPLC. For correction of the total amount of serotonergic neurons contained in prepared slices, basal extracellular 5-hydroxyindolacetic acid (5-HIAA) level of all slices was measured 1 day before drug treatment. All values obtained were divided and corrected by values of the basal 5-HIAA levels.
In the mesencephalic slice culture including the raphe nuclei, immunostaining for tryptophan hydroxylase (TPH), the rate-limiting enzyme in the biosynthesis of 5-HT, revealed that numerous TPH-positive cell bodies and neuritis were clearly observed. TPH-positive cell bodies localized in mainly two regions, which were thought to be the dorsal raphe nuclei and median raphe nuclei, suggesting that the slice culture retained the in vivo morphology of the raphe serotonergic neurons. In addition, the mesencephalic slice culture had abundant tissue contents of 5-HT and its metabolite 5-HIAA and showed abundant specific binding for [ (31) , and the decreases were attenuated by co-treatment with citalopram. These results suggest that the mesencephalic slice culture has functional serotonergic neurons and SERT and could be useful for studying raphe serotonergic neurons.
Single acute exposure of the mesencephalic slice culture to METH and MDMA dose-dependently caused 5-HT release in the buffer, suggesting that the slice culture has functional serotonergic nerve terminals. On the other hand, acute treatment with 5-MeO-DiPT had no effect on the 5-HT release. This finding is consistent with the recent report for the [ 3 H]5-HT release assay using rat brain synaptosome (5) .
It is known that METH and MDMA leads to a longterm depletion of 5-HT that has been correlated with destruction of serotonergic nerve terminals, which contributes to the toxic and neuropsychotoxic properties (30, 32) . However, in our mesencephalic slice culture, sustained exposure to METH and MDMA had little or no effects on the intracellular 5-HT tissue contents and [
3 H]citalopram binding, although serotonergic neurotoxin 5,7-DHT dramatically decreased them as described above. Although the specific mechanisms underlying METH-and MDMA-induced serotonergic neurotoxicity have not fully elucidated, it is proposed that free radicals metabolized from dopamine that is heterologously transported into serotonergic terminals by SERT may mediate serotonergic neurotoxicity (32) . The lack of serotonergic neurotoxicity by METH and MDMA in this study may be due to lack of a sufficient number of dopaminergic neurons or little interaction between dopaminergic and serotonergic neurons in the mesencephalic slice culture. Consistently, it was reported that systemic injection of MDMA produced serotonergic neurotoxicity, while local injection of MDMA into the brain had no effect (33) . On the other hand, sustained exposure to 5-MeO-DiPT dramatically decreased the intracellular 5-HT tissue contents and [
3 H]citalopram binding. These results suggest that 5-MeO-DiPT has potent neurotoxic effect on the serotonergic neurons ( Fig. 1) , consistent with previous behavioral reports (34) . However, it was reported that 5-MeO-DiPTinduced cell toxicity for COS-7 cells was independent of the expression of SERT (24) . Additional investigations will be needed to elucidate the mechanisms underlying the serotonergic neurotoxic effect of 5-MeO-DiPT.
To examine the chronic effect of MDMA and METH on 5-HT release, the mesencephalic slice culture was continuously exposed to MDMA and METH for 4 days. We found that the MDMA-induced 5-HT release was gradually augmented by sustained MDMA exposure. In addition, after 1-day cultivation in drug-free medium following the sustained exposure, challenge with MDMA to the sustained MDMA-exposed slices significantly increased 5-HT release, compared with that in the sustained PBS-exposed slices. Similar increase in 5-HT release was observed by sustained exposure to METH, although it was slightly weaker than MDMA. These results suggest that chronic treatment with MDMA and METH induces augmentation of their 5-HT-releasing effect, that is, serotonergic sensitization (Fig. 1) .
Consistent with the present study, it was recently reported that repeated treatments with amphetamines augmented 5-HT release in the PFC (8, 10) . Recent studies have suggested that the serotonergic neurons to limbic areas modulate the mesocorticolimbic dopaminergic-glutamatergic system (7) and implicated behavioral sensitization induced by amphetamines (8 -10) . It is conceivable that chronic MDMA-and METH-induced sensitization of raphe serotonergic neurons may partly contribute to neuropsychotoxic effect of drugs of abuse.
Conclusion
In the present study, we showed several new findings as follows: 1) In the Xenopus oocyte expression system, MDMA induced a transport-associated inward current response in SERT, rather than DAT, while 5-MeO-DiPT induced an apparent outward current response, probably due to blockade of the inward leak. Furthermore, the MDMA-induced transport-associated current was enhanced by acidic pH. 2) In the VTA / NAc/ mPFC triple slice culture, acute treatment with METH, cocaine, and morphine, but less so with MDMA, increased dopamine release. Repeated exposure to METH, morphine, and cocaine augmented dopamine release, that is, in vitro dopaminergic sensitization. The glutamatergic system from mPFC plays an essential role in the repeated METH-induced dopaminergic sensitization. 3) In the mesencephalic slice culture including the raphe serotonergic neurons, acute treatment with METH and MDMA, but not 5-MeO-DiPT, increased 5-HT release. Sustained exposure to MDMA and METH augmented 5-HT release, that is, in vitro serotonergic sensitization, while 5-MeO-DiPT produces serotonergic neurotoxicity. These findings may contribute to understanding the mechanisms underlying neuropsychotoxic effects of drugs of abuse.
